BioLineRx Ltd. (BLRX)

NASDAQ: BLRX · Real-Time Price · USD

3.44

0.00 (0.15%)

At close: May 02, 2025, 2:56 PM

BioLineRx Balance Sheet Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016
Cash & Equivalents	10.44M	4.25M	10.59M	12.99M	16.83M	5.3M	3.4M	5.11M	2.47M
Short-Term Investments	9.13M	38.74M	40.49M	44.15M	5.76M	22.19M	26.75M	44.37M	33.15M
Long-Term Investments	n/a	n/a	n/a	n/a	n/a	n/a	n/a	1M	n/a
Other Long-Term Assets	n/a	n/a	n/a	n/a	n/a	n/a	56K	61K	52K
Receivables	3.86M	358K	721K	142K	141K	613K	1.34M	586K	n/a
Inventory	3.15M	1.95M	197.08K	126.73K	151.71K	107.28K	n/a	-44.07M	n/a
Other Current Assets	n/a	830K	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Total Current Assets	27.1M	47.18M	52M	57.4M	22.88M	28.21M	31.98M	50.38M	36.1M
Property-Plant & Equipment	1.35M	1.89M	2.5M	2.28M	2.7M	3.47M	2.23M	2.5M	2.6M
Goodwill & Intangibles	10.45M	14.85M	21.89M	21.7M	21.71M	21.89M	21.97M	7.02M	181K
Total Long-Term Assets	11.8M	16.74M	24.38M	23.99M	24.41M	25.36M	24.25M	10.59M	2.84M
Total Assets	38.91M	63.92M	76.38M	81.39M	47.29M	53.57M	56.23M	60.97M	38.94M
Account Payables	5.58M	10.87M	6.97M	5.57M	5.92M	7.79M	4.49M	5.52M	2.59M
Deferred Revenue	n/a	12.96M	n/a	n/a	n/a	1.27M	1.35M	1.09M	963K
Short-Term Debt	4.48M	3.15M	1.54M	2.76M	3.09M	2.69M	895K	93K	93K
Other Current Liabilities	2.12M	12.35M	84K	2K	3K	7K	14K	19K	15K
Total Current Liabilities	15.41M	42.78M	10.68M	9.72M	10.64M	11.97M	6.75M	6.72M	3.66M
Long-Term Debt	8.96M	6.63M	8.63M	n/a	2.74M	5.8M	7.84M	157K	250K
Other Long-Term Liabilities	n/a	11.93M	4.51M	1.86M	10.22M	658K	323K	1.21M	1K
Total Long-Term Liabilities	10.04M	19.85M	14.86M	3.58M	14.62M	8.22M	8.16M	1.36M	251K
Total Liabilities	25.45M	50.7M	25.54M	13.3M	25.26M	20.19M	14.91M	8.08M	3.91M
Total Debt	15.04M	11.59M	12.32M	4.65M	7.68M	10.46M	8.73M	250K	343K
Common Stock	38.1M	31.36M	27.1M	21.07M	9.87M	4.69M	3.11M	2.84M	1.51M
Retained Earnings	-399.83M	-390.61M	-329.99M	-305.04M	-277.99M	-247.97M	-222.52M	-199.56M	-175.21M
Comprehensive Income	16.13M	16.99M	13.35M	11.74M	10.91M	10.72M	10.54M	8.92M	9.15M
Shareholders Equity	13.46M	13.22M	50.84M	68.09M	22.03M	33.38M	41.32M	52.88M	35.03M
Total Investments	9.13M	38.74M	40.49M	44.15M	5.76M	22.19M	26.75M	45.37M	33.15M